MIAMI, Dec. 13, 2007 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink sheets:GLSN) today announced that it has retained Hogan & Hartson LLP in connection with obtaining necessary approvals for Medicaid and other reimbursement programs in all 50 states for its Nutraplete Therapeutic Drink Mix. Nutraplete is the first therapeutic dietary supplement designed specifically for people living with HIV/AIDS. Nutraplete is manufactured and distributed through BioSource Therapeutics, Inc. a Galea Life Sciences, Inc. subsidiary.
